Search

Your search keyword '"Marta Molero"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Marta Molero" Remove constraint Author: "Marta Molero" Topic 03 medical and health sciences Remove constraint Topic: 03 medical and health sciences
17 results on '"Marta Molero"'

Search Results

1. Cerebrospinal Fluid Neopterin in Children With Enterovirus-Related Brainstem Encephalitis

2. Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Catalog

Books, media, physical & digital resources

3. Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders

4. Analysis of human cerebrospinal fluid monoamines and their cofactors by HPLC

5. Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors

6. Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases

7. Effect of blood contamination of cerebrospinal fluid on amino acids, biogenic amines, pterins and vitamins

8. Biochemical Analyses of Cerebrospinal Fluid for the Diagnosis of Neurometabolic Conditions. What Can We Expect?

9. Treatment of genetic defects of thiamine transport and metabolism

10. Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience

11. Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system

12. Pyridoxal Phosphate Supplementation in Neuropediatric Disorders

13. Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients

14. Biomarkers for the study of catecholamine and serotonin genetic diseases

15. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome

16. Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children

17. Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor